Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Machine Learning Applied to the Prediction of Relapse, Hospitalization, and Suicide in Bipolar Disorder Using Neuroimaging and Clinical Data: A Systematic Review Publisher Pubmed



Amanollahi M1 ; Jameie M2, 3 ; Looha MA4 ; A Basti F5 ; Cattarinussi G6, 7 ; Moghaddam HS1, 8 ; Di Camillo F6 ; Akhondzadeh S8 ; Pigoni A9 ; Sambataro F6, 7 ; Brambilla P9, 10 ; Delvecchio G9
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Neuroscience Research Center, Iran University of Medical Sciences, Tehran, Iran
  3. 3. Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  5. 5. Islamic Azad University, Tehran Medical Branch, Tehran, Iran
  6. 6. Department of Neuroscience (DNS), University of Padova, Padua, Italy
  7. 7. Padova Neuroscience Center, University of Padova, Italy
  8. 8. Psychiatry and Psychology Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran
  9. 9. Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
  10. 10. Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy

Source: Journal of Affective Disorders Published:2024


Abstract

Background: Bipolar disorder (BD) is associated with increased morbidity/mortality. Adverse outcome prediction might help with the management of patients with BD. Methods: We systematically reviewed the performance of machine learning (ML) studies in predicting adverse outcomes (relapse or recurrence, hospital admission, and suicide-related events) in patients with BD. Demographic, clinical, and neuroimaging-related poor outcome predictors were also reviewed. Three databases (PubMed, Scopus, and Web of Science) were explored from inception to July 2023. Results: Eighteen studies, accounting for >30,000 patients, were included. Support vector machine, decision trees, random forest, and logistic regression were the most frequently used ML algorithms. ML models' area under the receiver operating characteristic (ROC) curve (AUC), sensitivity, and specificity ranged from 0.71 to 0.98, 72.7–92.8 %, and 59.0–95.2 % for relapse/recurrence prediction (4 studies (3 on relapses and 1 on recurrences). The corresponding values were 0.78–0.88, 21.4–100 %, and 77.0–99.7 % for hospital admissions (3 studies, 21,266 patients), and 0.71–0.99, 44.4–97.9 %, and 38.9–95.0 % for suicide-related events (10 studies, 5558 patients). Also, one study addressed a combination of the interest outcomes. Adverse outcome predictors included early onset BD, BD type I, comorbid psychiatric or substance use disorder, circadian rhythm disruption, hospitalization characteristics, and neuroimaging parameters, including increased dynamic amplitude of low-frequency fluctuation, decreased frontolimbic functional connectivity and aberrant dynamic functional connectivity in corticostriatal circuitry. Conclusions: ML models can predict adverse outcomes of BD with relatively acceptable performance measures. Future studies with larger samples and nested cross-validation validation should be conducted to reach more reliable results. © 2024 Elsevier B.V.
Related Docs
Experts (# of related papers)